Aventis Ketek Approved By FDA; Antibiotic Launch Planned For Late July

Telithromycin is approved for the treatment of acute exacerbation of chronic bronchitis, acute bacterial sinusitis, and mild-to-moderate community acquired pneumonia. Phase IV commitments include pediatric studies in CAP and sinusitis.